Ulta Beauty Exiting Target (TGT) Shop Partnership By August 2026

Target (TGT) announced the non-renewal of its Ulta Beauty partnership, concluding in 2026. Amid this transition, the company introduced new product lines, such as Everyday Dose and My Better Batch, reflecting its continued retail innovation strategy. During the last quarter, Target's shares rose 8.5%, a movement that aligned with the overall market trend, as major indices showed strong performances. While the Ulta partnership phase-out and new product launches may have marginally influenced investor sentiment, Target's price move generally mirrors the broader market uplift, as signaled by record highs in key indices.

Every company has risks, and we've spotted 3 risks for Target (of which 1 is concerning!) you should know about.

Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

The non-renewal of Target's partnership with Ulta Beauty could reshape its future growth trajectory, as the company focuses on new product lines like Everyday Dose and My Better Batch. While these initiatives could potentially drive revenue through retail innovation, the absence of Ulta might reduce some in-store foot traffic. Over the past year, Target's total return, including both share price and dividends, saw a significant decline of 18.77%, highlighting some challenges in maintaining long-term growth. Comparatively, Target underperformed against the US Consumer Retailing industry, which enjoyed a substantial return over the same period, showcasing a gap in relative performance.

Target's current revenue stands at US$105.88 billion, with earnings of US$4.18 billion. However, future projections indicate a slight decrease in earnings while maintaining modest revenue growth. The introduction of new products and adjustments in corporate partnerships might offer fresh revenue channels, but the reliance on discretionary spending remains a risk. The analyst consensus suggests a current price target of US$102.97, which is marginally lower than the current share price of US$105.36, indicating a mixed market sentiment. Investors should assess these developments closely, given the economic uncertainties and potential impact on profit margins and earnings forecasts.

Unlock comprehensive insights into our analysis of Target stock in this financial health report.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com